In lung cancer, the accumulation of Tim-3-expressing lymphoid cells and galectin-9-expressing monocytic myeloid-derived suppressor cells positively correlates with resistance to anti-PD1 immunotherapy [312]. Here, LGALS9 is linked to lung cancer.